Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis

Simple item page
dc.contributor.authorCaruso, M.
dc.contributor.authorMoore, J.
dc.contributor.authorGoodall, G.
dc.contributor.authorThomas, M.
dc.contributor.authorPhillis, S.
dc.contributor.authorTyskin, A.
dc.contributor.authorCheetham, G.
dc.contributor.authorLerda, N.
dc.contributor.authorTakahashi, H.
dc.contributor.authorRuszkiewicz, A.
dc.date.issued2009
dc.description.abstractSessile serrated adenomas are now recognised as precursor lesions of a substantial subset of colorectal cancers arising via a so-called “serrated pathway”. However, their biological markers remain to be defined. The aim of our study was to identify differentially expressed genes in sessile serrated adenomas and conventional adenomas. Gene expression analysis demonstrated molecular differences between polyp types. Further studies using quantitative real-time polymerase chain reaction on cathepsin E (CTSE) demonstrated a significantly (p < 0.05) higher expression in sessile serrated adenomas as compared to hyperplastic polyp and tubular adenomas. Trefoil Factor 1 showed the same trend of expression for sessile serrated adenomas as compared to hyperplastic polyps and was significantly higher in both polyps compared to tubular adenomas. Immunohistochemistry for both proteins demonstrated strong cytoplasmic staining of abnormal crypts in all sessile serrated adenomas, while staining in tubular adenomas and hyperplastic polyps was absent or weak and focal. BRAF and KRAS mutation analysis were employed to further validate polyp discrimination. The findings demonstrated the positive association of the BRAF mutation, V600E, with sessile serrated adenomas and KRAS mutations with tubular adenomas (p < 0.05). This study demonstrates the over-expression in CTSE, in particular, and TFF1 in sessile serrated adenomas compared to both hyperplastic polyps and tubular adenomas.
dc.description.statementofresponsibilityMaria Caruso, James Moore, Gregory J. Goodall, Michelle Thomas, Stuart Phillis, Anna Tyskin, Glenice Cheetham, Nancy Lerda, Hiroyuki Takahashi and Andrew Ruszkiewicz
dc.identifier.citationVirchows Archiv: an international journal of pathology, 2009; 454(3):291-302
dc.identifier.doi10.1007/s00428-009-0731-0
dc.identifier.issn0945-6317
dc.identifier.issn1432-2307
dc.identifier.orcidGoodall, G. [0000-0003-1294-0692]
dc.identifier.orcidRuszkiewicz, A. [0000-0001-9052-4948]
dc.identifier.urihttp://hdl.handle.net/2440/53163
dc.language.isoen
dc.publisherSpringer
dc.source.urihttps://doi.org/10.1007/s00428-009-0731-0
dc.subjectSessile serrated adenoma
dc.subjectGene expression
dc.subjectColorectal cancer
dc.subjectCathepsin E
dc.subjectTrefoil factor 1
dc.subjectSerrated neoplasia pathway
dc.titleOver-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications